Table 1 Baseline characteristics*
CharacteristicsAll patientsPatients with STEMIPatients with NSTE-ACS
No AFAFNo AFAFNo AFAF
Patients (n).111 529903777 440672134 0892316
Age (years), median (25th, 75th)62.2 (53.0, 70.7)70.0 (63.0, 76.0)61.0 (51.7, 69.7)69.4 (62.0, 75.9)65.0 (56.0, 72.2)71.0 (65.0, 77.0)
Female27.431.824.530.934.2†34.2†
Race
    White90.994.991.895.589.093.2
    Black3.11.52.41.24.62.5
    Other6.03.65.83.36.44.4
Smoking status
    Never31.637.928.736.238.342.7
    Previous29.235.227.033.234.240.9
    Current39.126.944.330.627.516.4
Killip class
    I87.976.487.375.689.178.9
    II10.519.411.019.89.217.9
    III1.22.91.13.01.32.8
    IV0.51.30.51.60.40.4
Region
    North America47.457.047.456.947.557.5
    Western Europe35.528.334.827.937.029.4
    Eastern Europe3.72.72.11.47.46.6
    Latin America1.20.41.70.60.00.0
    Australia6.98.07.28.76.46.1
    Other5.33.56.84.51.70.5
Weight (kg), median (25th, 75th)78.0 (69.0, 88.0)77.0 (68.0, 86.9)78.0 (70.0, 88.0)77.0 (68.0, 86.0)78.0 (68.0, 88.7)¶77.3 (68.0, 88.0)¶
Height (cm), median (25th, 75th)170.0 (164.0, 177.0)‡170.1 (163.0, 177.3)‡171.0 (165.0, 177.3)**170.1 (164.0, 177.5)**170.0 (162.6, 176.0)††170.0 (163.0, 177.0)††
BP (mm Hg), median (25th, 75th)
    Systolic130.0 (117.0, 150.0)130.0 (112.0, 146.0)130.0 (115.0, 149.0)128.0 (110.0, 145.0)133.0 (120.0, 150.0)‡‡132.0 (120.0, 150.0)‡‡
    Diastolic80.0 (70.0, 90.0)77.0 (66.0, 86.0)80.0 (70.0, 90.0)78.0 (66.0, 88.0)78.0 (68.0, 85.0)75.0 (65.0, 84.0)
Heart rate (bpm), median (25th, 75th)72.0 (62.0, 84.0)75.0 (63.0, 90.0)73.0 (62.0, 85.0)75.0 (63.0, 90.0)72.0 (63.0, 82.0)75.0 (65.0, 88.0)
Prior CABG6.9§6.0§4.0§§4.4§§13.410.9
Prior hypertension43.650.537.945.756.464.4
Prior CHF4.17.61.94.99.115.7
Prior diabetes mellitus17.620.615.218.323.027.4
Prior PCI7.76.54.8¶¶4.4¶¶14.5***12.3***
Prior MI20.624.216.120.830.7§33.8§
US patient38.547.739.148.737.044.8
Prior CVA, stroke, or TIA3.45.42.03.85.78.9
  • Data are presented as percentages unless otherwise indicated.

  • *Significant differences existed between no AF and AF in all groups of patients except where indicated. Significance was defined as p<0.001 owing to sample size. †p = 0.975; ‡p = 0.889; §p = 0.002; ¶p = 0.357; **p = 0.033; ††p = 0.008; ‡‡p = 0.080; §§p = 0.181; ¶¶p = 0.248; ***p = 0.004.

  • AF, atrial fibrillation. BP, blood pressure; CABG, coronary artery bypass grafting; CHF, congestive heart failure; CVA, cerebrovascular accident; MI, myocardial infarction; NSTE-ACS, non-ST-segment elevation acute coronary syndrome; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; TIA, transient ischaemic attack.